- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Mankind Pharma has allotted 29,742 new equity shares, each at a face value of Re. 1, to eligible employees who exercised their options under the ESOP Plan 2022. This issuance increases the company's total paid-up equity shares from 41,27,28,748 to 41,27,58,490. Employees acquired these shares at an exercise price of Rs. 860 per share, including a premium of Rs. 859. This move expands employee ownership, aligning incentives and supporting the company's growth strategy.